UNSPSC 51283112: Gramicidin

This classification denotes an anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5IE62321P4. European Medicines Agency schedules Gramicidin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02403MIG. Gramicidin generally arises in the molecular formula C60H92N12O10.

UNSPSC 51283112 Gramicidin, a Commodity code, does not align with the recent state and local opportunities tagged under it. The posted solicitations—naloxone procurement, therapeutic pharmacy initiative planning, medical and first aid supplies, and generic pharmaceuticals through cooperative purchasing—address pharmaceutical and medical supply acquisition broadly but do not reference gramicidin specifically or pharmaceutical manufacturing and distribution of gramicidin as an active ingredient. The code shows minimal relevant recent activity, with posted opportunities focused instead on finished-goods procurement, pharmacy benefit program design, and multi-state cooperative pharmaceutical sourcing rather than gramicidin as a standalone commodity.

The issuing bodies across recent opportunities span state health agencies, county health departments, municipal purchasing offices, and state-led cooperative purchasing alliances. Texas Health and Human Services Commission issued an RFI on direct-to-manufacturer prescriptions with a March 27, 2026 posting and April 3, 2026 response date. Seminole County, Florida solicited naloxone and drug deactivation systems through IFB 60459723LAS, posted June 30, 2026, with a July 26, 2023 due date. The City of Tampa released IFB 26-P-00145 for medical and first aid supplies on March 25, 2026, due March 13, 2026, designated as a sheltered market for certified Small Local Business Enterprises with an estimated contract value of $700,000. Minnesota's MMCAP cooperative purchasing alliance posted RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products on January 20, 2026, with a March 26, 2026 proposal deadline, serving participating states including Oregon. Recent activity concentrates in Florida, Texas, and the upper Midwest, though the gramicidin code itself does not map clearly to these actual procurements.